Anticancer activity of ginsenosides Rh2 on various cancer cells
Background: This study has mainly focused on finding pharmacological effects of ginsenosides that can reduce the unwanted side effects of the cytotoxic anticancer drugs and are highly effective on prostate cancer, colorectal cancer, liver cancer, hormone-dependent breast cancer, triple-negative brea...
| Published in: | Journal of Animal Reproduction and Biotechnology |
|---|---|
| Main Authors: | Seun Eui Kim, Myoung-Hoon Lee, Hye-Myoung Jang, Wan-Taek Im, Joontaik Lee, Sang-Hwan Kim, Gwang Joo Jeon |
| Format: | Article |
| Language: | English |
| Published: |
The Korean Society of Animal Reproduction and Biotechnology
2023-09-01
|
| Subjects: | |
| Online Access: | https://www.e-jarb.org/journal/view.html?uid=2663&vmd=Full |
Similar Items
A rare ginsenoside compound K (CK) induces apoptosis for breast cancer cells
by: Seun Eui Kim, et al.
Published: (2023-09-01)
by: Seun Eui Kim, et al.
Published: (2023-09-01)
Protective effect of ginsenoside Rh3 against anticancer drug-induced apoptosis in LLC-PK1 kidney cells
by: Hye Lim Lee, et al.
Published: (2017-04-01)
by: Hye Lim Lee, et al.
Published: (2017-04-01)
Glycosyltransformation of ginsenoside Rh2 into two novel ginsenosides using recombinant glycosyltransferase from Lactobacillus rhamnosus and its in vitro applications
by: Dan-Dan Wang, et al.
Published: (2021-01-01)
by: Dan-Dan Wang, et al.
Published: (2021-01-01)
20 (S)-ginsenoside Rh2 inhibits colorectal cancer cell growth by suppressing the Axl signaling pathway in vitro and in vivo
by: Haibo Zhang, et al.
Published: (2022-05-01)
by: Haibo Zhang, et al.
Published: (2022-05-01)
Immunomodulatory Activities of Emerging Rare Ginsenosides F1, Rg5, Rk1, Rh1, and Rg2: From Molecular Mechanisms to Therapeutic Applications
by: Chang-Eui Hong, et al.
Published: (2025-10-01)
by: Chang-Eui Hong, et al.
Published: (2025-10-01)
Differential antiangiogenic and anticancer activities of the active metabolites of ginsenoside Rg3
by: Maryam Nakhjavani, et al.
Published: (2024-03-01)
by: Maryam Nakhjavani, et al.
Published: (2024-03-01)
Inhibitory Effect of Exosomes Loaded with Ginsenoside Rh2 on Growth of Hepatocellular Carcinoma Cells
by: Meile LI, et al.
Published: (2025-07-01)
by: Meile LI, et al.
Published: (2025-07-01)
Protective effect of ginsenosides Rk3 and Rh4 on cisplatin-induced acute kidney injury in vitro and in vivo
by: Seung-Hoon Baek, et al.
Published: (2017-07-01)
by: Seung-Hoon Baek, et al.
Published: (2017-07-01)
The ways for ginsenoside Rh2 to fight against cancer: the molecular evidences in vitro and in vivo.
by: Qi-rui Hu, et al.
Published: (2023-03-01)
by: Qi-rui Hu, et al.
Published: (2023-03-01)
Research Progress on Effects of Ginsenoside Rg2 and Rh1 on Nervous System and Related Mechanisms
by: Silu Liu, et al.
Published: (2023-12-01)
by: Silu Liu, et al.
Published: (2023-12-01)
Facile approach for surfactant-free synthesis of Au@ginsenoside Rh2 nanoparticles and researches on anticancer activity
by: Hua Yao, et al.
Published: (2022-10-01)
by: Hua Yao, et al.
Published: (2022-10-01)
Antiviral activity of 20(R)-ginsenoside Rh2 against murine gammaherpesvirus
by: Soowon Kang, et al.
Published: (2017-10-01)
by: Soowon Kang, et al.
Published: (2017-10-01)
Synergistic Effect of Ginsenoside Rh2 Combines with Ionizing Radiation on CT26/<i>luc</i> Colon Carcinoma Cells and Tumor-Bearing Animal Model
by: Shan-Chih Lee, et al.
Published: (2023-08-01)
by: Shan-Chih Lee, et al.
Published: (2023-08-01)
Probable Mechanisms of Doxorubicin Antitumor Activity Enhancement by Ginsenoside Rh2
by: Alexander Popov, et al.
Published: (2022-01-01)
by: Alexander Popov, et al.
Published: (2022-01-01)
Nanoparticle conjugation of ginsenoside Rh2 enhanced antitumor efficacy on hepatocellular carcinoma
by: Fengkai Sun, et al.
Published: (2025-08-01)
by: Fengkai Sun, et al.
Published: (2025-08-01)
Biosynthesis of a Novel Ginsenoside with High Anticancer Activity by Recombinant UDP-Glycosyltransferase and Characterization of Its Biological Properties
by: Dandan Wang, et al.
Published: (2025-02-01)
by: Dandan Wang, et al.
Published: (2025-02-01)
Co-loaded simvastatin-ginsenoside Rh2 liposomes enhance cellular immune responses as vaccine adjuvants
by: Yinxiu Huang, et al.
Published: (2025-09-01)
by: Yinxiu Huang, et al.
Published: (2025-09-01)
How Does Ginsenoside Rh2 Mitigate Adipogenesis in Cultured Cells and Obese Mice?
by: Longyun Zhang, et al.
Published: (2020-05-01)
by: Longyun Zhang, et al.
Published: (2020-05-01)
Mechanism for ginsenoside Rh2-induced apoptosis of triple-negative breast cancer MDA-MB-231 cells
by: Y. Zeng, et al.
Published: (2020-02-01)
by: Y. Zeng, et al.
Published: (2020-02-01)
Bioinformatics study of the potential therapeutic effects of ginsenoside Rh3 in reversing insulin resistance
by: Yayun Wang, et al.
Published: (2024-05-01)
by: Yayun Wang, et al.
Published: (2024-05-01)
Ginsenoside Rh2 upregulates long noncoding RNA STXBP5-AS1 to sponge microRNA-4425 in suppressing breast cancer cell proliferation
by: Jae Eun Park, et al.
Published: (2021-11-01)
by: Jae Eun Park, et al.
Published: (2021-11-01)
Ginsenoside Rh2 repressed the progression of prostate cancer through the mitochondrial damage induced by mitophagy and ferroptosis
by: Zhen He, et al.
Published: (2025-08-01)
by: Zhen He, et al.
Published: (2025-08-01)
Transcriptome Analysis of the Anti-Proliferative Effects of Ginsenoside Rh3 on HCT116 Colorectal Cancer Cells
by: Siying Teng, et al.
Published: (2022-08-01)
by: Siying Teng, et al.
Published: (2022-08-01)
Ginsenoside Rh3 Inhibits Lung Cancer Metastasis by Targeting Extracellular Signal-Regulated Kinase: A Network Pharmacology Study
by: Xiaodan Xue, et al.
Published: (2022-06-01)
by: Xiaodan Xue, et al.
Published: (2022-06-01)
Ginsenoside Rh2 attenuates microglial activation against toxoplasmic encephalitis via TLR4/NF-κB signaling pathway
by: Xiang Xu, et al.
Published: (2020-09-01)
by: Xiang Xu, et al.
Published: (2020-09-01)
c-MYC-mediated TRIB3/P62+ aggresomes accumulation triggers paraptosis upon the combination of everolimus and ginsenoside Rh2
by: Min-Xia Su, et al.
Published: (2022-03-01)
by: Min-Xia Su, et al.
Published: (2022-03-01)
Ginsenoside Rh2 inhibits breast cancer cell growth via<?A3B2 ACK?>ERβ-TNFα pathway
by: Peng Kunjian, et al.
Published: (2022-05-01)
by: Peng Kunjian, et al.
Published: (2022-05-01)
Ginsenoside Rh2 shifts tumor metabolism from aerobic glycolysis to oxidative phosphorylation through regulating the HIF1-α/PDK4 axis in non-small cell lung cancer
by: Xiyu Liu, et al.
Published: (2024-04-01)
by: Xiyu Liu, et al.
Published: (2024-04-01)
Ginsenoside Rh2 administration produces crucial antidepressant‐like effects in a CUMS‐induced mice model of depression
by: Lin‐Sheng Shi, et al.
Published: (2022-08-01)
by: Lin‐Sheng Shi, et al.
Published: (2022-08-01)
Ginsenoside Rh2 reduces depression in offspring of mice with maternal toxoplasma infection during pregnancy by inhibiting microglial activation via the HMGB1/TLR4/NF-κB signaling pathway
by: Xiang Xu, et al.
Published: (2022-01-01)
by: Xiang Xu, et al.
Published: (2022-01-01)
Ginsenoside Rh4 Improves Hepatic Lipid Metabolism and Inflammation in a Model of NAFLD by Targeting the Gut Liver Axis and Modulating the FXR Signaling Pathway
by: Siming Yang, et al.
Published: (2023-06-01)
by: Siming Yang, et al.
Published: (2023-06-01)
Ginsenoside Rh4 alleviates idiopathic pulmonary fibrosis by enhancing the CXCL9–CXCR3 axis
by: Lei Yao, et al.
Published: (2024-05-01)
by: Lei Yao, et al.
Published: (2024-05-01)
(20S) Ginsenoside Rh2-Activated, Distinct Apoptosis Pathways in Highly and Poorly Differentiated Human Esophageal Cancer Cells
by: He Li, et al.
Published: (2022-08-01)
by: He Li, et al.
Published: (2022-08-01)
Ginsenoside Rh1 Exerts Neuroprotective Effects by Activating the PI3K/Akt Pathway in Amyloid-β Induced SH-SY5Y Cells
by: Miey Park, et al.
Published: (2021-06-01)
by: Miey Park, et al.
Published: (2021-06-01)
Influence of <i>Auricularia cornea</i> Polysaccharide Coating on the Stability and Antioxidant Activity of Liposomes Ginsenoside Rh2
by: Minghui Wang, et al.
Published: (2023-10-01)
by: Minghui Wang, et al.
Published: (2023-10-01)
Ginsenoside Rh2 Induces HeLa Apoptosis through Upregulating Endoplasmic Reticulum Stress-Related and Downstream Apoptotic Gene Expression
by: Ying Liu, et al.
Published: (2022-11-01)
by: Ying Liu, et al.
Published: (2022-11-01)
Ginsenoside Rh2 alleviates inflammatory response and enhances motor function recovery in spinal cord injury mice via the ROS/MAPK14 signaling pathway
by: Yanlan Wu, et al.
Published: (2025-07-01)
by: Yanlan Wu, et al.
Published: (2025-07-01)
Ginsenoside Rh2 reduces m6A RNA methylation in cancer via the KIF26B-SRF positive feedback loop
by: Chunmei Hu, et al.
Published: (2021-11-01)
by: Chunmei Hu, et al.
Published: (2021-11-01)
Ginsenoside Rh2 augmented anti-PD-L1 immunotherapy by reinvigorating CD8+ T cells via increasing intratumoral CXCL10
by: Mu-Yang Huang, et al.
Published: (2023-12-01)
by: Mu-Yang Huang, et al.
Published: (2023-12-01)
Ginsenoside Rh3 induces pyroptosis and ferroptosis through the Stat3/p53/NRF2 axis in colorectal cancer cells
by: Wu Yingchao, et al.
Published: (2023-04-01)
by: Wu Yingchao, et al.
Published: (2023-04-01)
Similar Items
-
A rare ginsenoside compound K (CK) induces apoptosis for breast cancer cells
by: Seun Eui Kim, et al.
Published: (2023-09-01) -
Protective effect of ginsenoside Rh3 against anticancer drug-induced apoptosis in LLC-PK1 kidney cells
by: Hye Lim Lee, et al.
Published: (2017-04-01) -
Glycosyltransformation of ginsenoside Rh2 into two novel ginsenosides using recombinant glycosyltransferase from Lactobacillus rhamnosus and its in vitro applications
by: Dan-Dan Wang, et al.
Published: (2021-01-01) -
20 (S)-ginsenoside Rh2 inhibits colorectal cancer cell growth by suppressing the Axl signaling pathway in vitro and in vivo
by: Haibo Zhang, et al.
Published: (2022-05-01) -
Immunomodulatory Activities of Emerging Rare Ginsenosides F1, Rg5, Rk1, Rh1, and Rg2: From Molecular Mechanisms to Therapeutic Applications
by: Chang-Eui Hong, et al.
Published: (2025-10-01)
